|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.50 EUR | +1.30% |
|
+4.02% | +4.13% |
| 14/01 | Valmet Receives New Tissue Line Order in Algeria | MT |
| 14/01 | Valmet Will Support Faderco Group Doubles Tissue Production Capacity with A Third Advantage Dct Tissue Line | CI |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | 6 | |||||||
| 10 | |||||||
| 11 | |||||||
| 11 | |||||||
| 9 | |||||||
| 8 | |||||||
| 3 | |||||||
| 9 | |||||||
| 5 | |||||||
| 7 | |||||||
| 3 | |||||||
| 4 | |||||||
| 5 | |||||||
| 2 | |||||||
| 5 | |||||||
| 3 | |||||||
| 7 | |||||||
| - | - | ||||||
| - | - | ||||||
| Average | 6 | |||||||
| Weighted average by Cap. | 8 |
- Stock Market
- Equities
- VALMT Stock
- Sector Valmet Oyj
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition